From the publishers of JADPRO

Biomarkers in NSCLC Resource Center

Advertisement

Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment

Investigators found that a combination of a blood-based four-marker protein panel with the prostate lung colorectal ovarian (PLCO)m2012 lung cancer prediction model significantly improved lung cancer risk assessment compared with current US Preventive Services Task Force (USPSTF) criteria.

Journal of Clinical Oncology
Advertisement
News & Literature Highlights
Advertisement
Advertisement